Spots that claim a drug has caused serious side effects or death can affect how patients take their medicine and how doctors prescribe it, according to research from the Partnership to Protect Patient Health.
Not surprisingly, transparency and personalization top the list of patient priorities.
Data from Rock Health suggests digital health tools aren’t as popular as some might believe.
Investors continue to pour money into digital health.
HCPs are still OK with hearing from pharma and medical device marketers as long as it’s by email.
Vital Health is driven by Ketchum’s new analytics tool, Vital Diagnostics.
Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.
Medical science liaisons are essential participants in most aspects of the commercialization process.
Stuart Ingis on the benefits of showing the public how advertisers and marketers use data and creating a global regulatory framework.
Califf spoke about the importance of more data to faster and cheaper drug development at the NewYorkBIO conference.
Please login or register first to view this content.
